JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marsh, D. F.
Right arrow Articles by Howard, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marsh, D. F.
Right arrow Articles by Howard, A.
Journal of Pharmacology And Experimental Therapeutics, Vol. 103, Issue 2, 172-177, 1951
Copyright © 1951 by American Society for Pharmacology and Experimental Therapeutics


VERATRAMINE

David F. Marsh 1, D. A. Herring 1, and A. Howard 1

1 Department of Pharmacology, West Virginia University School of Medicine, Morgantown, W. Va.

Veratramine (200-600 microgm./kgm.) lowers the blood pressure, decreases the heart rate, produces muscular rigidity and clonic convulsions in the pentobarbitalized rat. It produces some antagonism of the heart rate increase caused by epinephrine and N-isopropylarterenol.

As little as 160 microgm. of veratramine pet kgm. produce some muscular rigidity, and myoclonic jerks, decreased heart rate, and lowered blood pressure in the anesthetized dog. As the dose is increased to 1 mgm. per kgm. the effects gradually become mote pronounced with clonic convulsions, increased respiration, low blood pressure and very slow heart rate. The effects are not altered by atropine. The cardiac acceleration produced by 2-3 microgm. of epinephrine per kgm. can be antagonized as much as 70 per cent although the antagonism of larger amounts of epinephrine and of similar amounts of N-isopropylarterenol is less. The antiacceleratory action is more pronounced in unanesthetized and thiopental-depressed dogs, is less with pentobarbital anesthesia, and is least with ether or sodium barbital.

In a single experiment, 250 microgm. of veratramine pet kgm., taken orally, were not well tolerated in man.

Submitted on June 28, 1951







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1951 by the American Society for Pharmacology and Experimental Therapeutics.